FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Gallagher

Research Profile

Disorders

Chemicals & Drugs

Physiology

Living Beings

Anatomy

Procedures

Remission Induction

Phenomena

Nucleic Acid Hybridization

Co-author Network

Publications

TOP 3
Robert E Gallagher; Richard Harvey; Rhett P Ketterling; Greg Koval; Richard A Larson; Barry K Moser; Elisabeth Paietta; Xavier Poiré; Bayard L Powell; Janis Racevskis; Diane Roulston; Esther Schachter-Tokarz; Dorie A Sher; Frederick R Appelbaum; Clara D Bloomfield; Andrew J Carroll; I-Ming L Chen; James H Feusner; Martin S Tallman; Cheryl L Willman; Da-Cheng Zhou; Wendy Stock
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia.
XiaoMei Liu; Charisse Loder; John Mandeli; Jonathan Melamed; Carole Oddoux; Ruifang Qiao; Pamela D Unger; Enrique Carrillo-de Santa Pau; Robert E Gallagher; Alejandro Gomez-Pinillos; Ralf Kurek; Anna C Ferrari
KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.
Eduardo M Rego; Raul Ribeiro; Guillermo J Ruiz-Argüelles; Maria del Rosario Uriarte; Rosane Bittencourt; Maria de Lourdes L F Chauffaille; Carlos Chiattone; Evandro M Fagundes; Robert E Gallagher; Javier Garcés-Eisele; David Gómez-Almaguer; Homero Gutiérrez-Aguirre; Rafael H Jacomo; Haesook T Kim; Hau Kwaan; Francesco LoCoco; Bob Lowenberg; Lem Martinez; Luis A Meillón; Raul A M Melo; Charlotte M Niemeyer; Katia Pagnano; Ricardo Pasquini; Miguel A Sanz
The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Gallagher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Robert E Gallagher; Richard Harvey; Rhett P Ketterling; Greg Koval; Richard A Larson; Barry K Moser; Elisabeth Paietta; Xavier Poiré; Bayard L Powell; Janis Racevskis; Diane Roulston; Esther Schachter-Tokarz; Dorie A Sher; Frederick R Appelbaum; Clara D Bloomfield; Andrew J Carroll; I-Ming L Chen; James H Feusner; Martin S Tallman; Cheryl L Willman; Da-Cheng Zhou; Wendy Stock
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia.
Blood 2012;120(10):2098-108.
2012: XiaoMei Liu; Charisse Loder; John Mandeli; Jonathan Melamed; Carole Oddoux; Ruifang Qiao; Pamela D Unger; Enrique Carrillo-de Santa Pau; Robert E Gallagher; Alejandro Gomez-Pinillos; Ralf Kurek; Anna C Ferrari
KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.
The American journal of pathology 2012;181(3):1007-16.
2012: Eduardo M Rego; Raul Ribeiro; Guillermo J Ruiz-Argüelles; Maria del Rosario Uriarte; Rosane Bittencourt; Maria de Lourdes L F Chauffaille; Carlos Chiattone; Evandro M Fagundes; Robert E Gallagher; Javier Garcés-Eisele; David Gómez-Almaguer; Homero Gutiérrez-Aguirre; Rafael H Jacomo; Haesook T Kim; Hau Kwaan; Francesco LoCoco; Bob Lowenberg; Lem Martinez; Luis A Meillón; Raul A M Melo; Charlotte M Niemeyer; Katia Pagnano; Ricardo Pasquini; Miguel A Sanz
The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL).
Hematology (Amsterdam, Netherlands) 2012;17 Suppl 1():S36-8.
2012: Jay P Patel; Janis Racevskis; Jacob M Rowe; Nicholas D Socci; Zhuoxin Sun; Martin S Tallman; Sabrena Thomas; Marcel R M van den Brink; Pieter Van Vlierberghe; Gail Vance; Agnes Viale; Mark Litzow; Selina Luger; Ari Melnick; Elisabeth Paietta; Omar Abdel-Wahab; Olga Aminova; Janice Cheng; Athena Cherry; Igor Dolgalev; Hugo Fernandez; Adolfo Ferrando; Maria E Figueroa; Robert E Gallagher; Mithat Gönen; Adriana Heguy; Rodney R Higgins; Kety Huberman; Rhett P Ketterling; Hillard M Lazarus; Ross L Levine
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
The New England journal of medicine 2012;366(12):1079-89.
2011: Robert E Gallagher
Mutants strike again in APL.
Blood 2011;118(6):1432-4.
2010: Martin S Tallman; Haesook T Kim; Pau Montesinos; Frederick R Appelbaum; Javier de la Serna; John M Bennett; Guillermo Deben; Clara D Bloomfield; Jose Gonzalez; James H Feusner; Marcos Gonzalez; Robert E Gallagher; Jose D Gonzalez-San Miguel; Richard A Larson; Gustavo Milone; Elisabeth Paietta; Chelo Rayon; Jacob M Rowe; Concha Rivas; Charles Alan Schiffer; Edo Vellenga; Lois Shepherd; James L Slack; Peter H Wiernik; Cheryl L Willman; Miguel A Sanz
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
Blood 2010;116(25):5650-9.
2010: Yongli Guo; Andrey V Dolinko; Fadzai Chinyengetere; Bruce Stanton; Jennifer M Bomberger; Eugene Demidenko; Da-Cheng Zhou; Robert E Gallagher; Tian Ma; Fabrizio Galimberti; Xi Liu; David Sekula; Sarah Freemantle; Ethan Dmitrovsky
Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia.
Cancer research 2010;70(23):9875-85.
2010: Bayard L Powell; Barry Moser; Wendy Stock; Robert E Gallagher; Cheryl L Willman; Richard M Stone; Jacob M Rowe; Steven Coutre; James H Feusner; John Gregory; Stephen Couban; Frederick R Appelbaum; Martin S Tallman; Richard A Larson
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.
Blood 2010;116(19):3751-7.
2010: Carolina Schinke; Swati Goel; Tushar D Bhagat; Li Zhou; Yongkai Mo; Robert E Gallagher; George W Kabalka; Leonidas C Platanias; Amit Verma; Bhaskar Das
Design and synthesis of novel derivatives of all-trans retinoic acid demonstrate the combined importance of acid moiety and conjugated double bonds in its binding to PML-RAR-alpha oncogene in acute promyelocytic leukemia.
Leukemia & lymphoma 2010;51(6):1108-14.
2010: Steven D Gore; Ivana Gojo; Mikkael A Sekeres; Lawrence Morris; Marcel Devetten; Katarzyna Jamieson; Robert L Redner; Robert J Arceci; Ibitayo Owoeye; Tianna Dauses; Esther Schachter-Tokarz; Robert E Gallagher
Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(6):1047-53.
2010: E Schachter-Tokarz; C Kelaidi; B Cassinat; C Chomienne; C Gardin; E Raffoux; H Dombret; P Fenaux; Robert E Gallagher
PML-RARalpha ligand-binding domain deletion mutations associated with reduced disease control and outcome after first relapse of APL.
Leukemia 2010;24(2):473-6.
2009: Robert E Gallagher
Real-time consensus on relapse risk in acute promyelocytic leukemia.
Leukemia research 2009;33(9):1170-2.
2008: Robert E Gallagher
SCANning for PML nuclear bodies with Myeloid Zinc Finger 1.
Leukemia research 2008;32(11):1650-2.
2008: Sutisak Kitareewan; Steven Blumen; David Sekula; Reid P Bissonnette; William W Lamph; Qingping Cui; Robert E Gallagher; Ethan Dmitrovsky
G0S2 is an all-trans-retinoic acid target gene.
International journal of oncology 2008;33(2):397-404.
2008: A Glasow; Angela Barrett; Kevin Petrie; Rajeev Gupta; Manuel Boix-Chornet; Da-Cheng Zhou; David Grimwade; Robert E Gallagher; Marieke von Lindern; Samuel Waxman; Tariq Enver; Guido Hildebrandt; Arthur Zelent
DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia.
Blood 2008;111(4):2374-7.
2006: Mark R Litzow; Sandra Lee; John M Bennett; Gordon W Dewald; Robert E Gallagher; Vibha Jain; Elisabeth Paietta; Janis Racevskis; Steven R Rousey; Joseph J Mazza; Martin S Tallman
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.
Haematologica 2006;91(8):1105-8.
2006: Anna C Ferrari; Nelson N Stone; Ralf Kurek; Elizabeth Mulligan; Roy McGregor; Richard Stock; Pamela Unger; Ulf Tunn; Amir Kaisary; Michael Droller; Simon Hall; Heiner Renneberg; Kenneth J Livak; Robert E Gallagher; John Mandeli
Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3081-8.
2006: Robert E Gallagher; E L Schachter-Tokarz; Da-Cheng Zhou; Wei Ding; Soon H Kim; B J Sankoorikal; Wanli Bi; Kenneth J Livak; James L Slack; Cheryl L Willman
Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure.
Leukemia 2006;20(4):556-62.
2005: Janice P Dutcher; Sandra Lee; Robert E Gallagher; Adel Z Makary; John D Hines; Harold Londer; John P Farnen; john bennett; Elisabeth Paietta; Jacob M Rowe; Olga Goloubeva; Peter H Wiernik
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).
Leukemia & lymphoma 2005;46(3):377-85.
2004: Y Sun; Soon H Kim; Da-Cheng Zhou; Wei Ding; Elisabeth Paietta; Fabien Guidez; Arthur Zelent; K.H. Ramesh; Linda Cannizzaro; R P Warrell; Robert E Gallagher
Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide.
Leukemia 2004;18(7):1258-69.
2004: Elisabeth Paietta; Olga Goloubeva; Donna Neuberg; John M Bennett; Robert E Gallagher; Janis Racevskis; Gordon Dewald; Peter H Wiernik; Martin S Tallman
A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
Cytometry. Part B, Clinical cytometry 2004;59(1):1-9.
2004: Wing Y Au; Randy D Gascoyne; Robert E Gallagher; Nhu Le; R D Klasa; R H S Liang; C Choy; W Foo; Joseph Michael Connors
Hodgkin's lymphoma in Chinese migrants to British Columbia: a 25-year survey.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(4):626-30.
2004: Carmela Gurrieri; Khedoudja Nafa; Taha Merghoub; Rosa Bernardi; Paola Capodieci; Andrea Biondi; Stephen D Nimer; Dan Douer; Carlos Cordon-Cardo; Robert E Gallagher; Pier Paolo Pandolfi
Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia.
Blood 2004;103(6):2358-62.
2003: Robert E Gallagher; Beow Y Yeap; Wanli Bi; Kenneth J Livak; Nike Beaubier; Sreenivas Rao; Clara D Bloomfield; Frederick R Appelbaum; Martin S Tallman; James L Slack; Cheryl L Willman
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.
Blood 2003;101(7):2521-8.
2002: Robert E Gallagher
Retinoic acid resistance in acute promyelocytic leukemia.
Leukemia 2002;16(10):1940-58.
2002: Bai-Wei Gu; Hui Xiong; Yan Zhou; Bing Chen; Li Wang; Shuo Dong; Zhi-Yuan Yu; Ling-Feng Lu; Ming Zhong; Hai-Feng Yin; Gen-Feng Zhu; Wei Huang; Shuang-Xi Ren; Robert E Gallagher; Samuel Waxman; Guo-Qiang Chen; Zhu-Gang Wang; Zhu Chen; Gang Fu; Sai-Juan Chen
Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(11):7640-5.
2002: Da-Cheng Zhou; Soon H Kim; Wei Ding; Cynthia Schultz; Raymond P Warrell; Robert E Gallagher
Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo.
Blood 2002;99(4):1356-63.
2001: James L Slack; Wanli Bi; Kenneth J Livak; Nike Beaubier; M Yu; M Clark; Soon H Kim; Robert E Gallagher; Cheryl L Willman
Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reaction.
The Journal of molecular diagnostics : JMD 2001;3(4):141-9.
2001: Jun Zhu; Clare Heyworth; A Glasow; QH Huang; Kevin Petrie; M Lanotte; G Benoit; Robert E Gallagher; Samuel Waxman; Tariq Enver; Arthur Zelent
Lineage restriction of the RARalpha gene expression in myeloid differentiation.
Blood 2001;98(8):2563-7.
2001: Robert E Gallagher
Co-biomodulation with arsenic trioxide in multiple myeloma.
Leukemia research 2001;25(3):237-9.
2000: R Bonomi; H Giordano; M del Pilar Moreno; E Bodega; AI Landoni; Robert E Gallagher; M del Rosario Uriarte
Simultaneous PML/RARalpha and AML1/ETO expression with t(15;17) at onset and relapse with only t(8;21) in an acute promyelocytic leukemia patient.
Cancer genetics and cytogenetics 2000;123(1):41-3.
2000: Sylvie Côté; D Zhou; Andrea Bianchini; Clara Nervi; Robert E Gallagher; Wilson H Miller
Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia.
Blood 2000;96(9):3200-8.
2000: James L Slack; Cheryl L Willman; J W Andersen; YP Li; David S Viswanatha; Clara D Bloomfield; Martin S Tallman; Robert E Gallagher
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129.
Blood 2000;95(2):398-403.
1999: X J Huang; Peter H Wiernik; Robert S Klein; Robert E Gallagher
Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases.
Medical oncology (Northwood, London, England) 1999;16(1):58-64.
1999: C Brigati; L Nobile; G Fugazza; M Zohouri; Robert E Gallagher; Linda Cannizzaro
A unique carboxy-terminus truncation mutant of the retinoic acid receptor alpha gene associated with a variant marker chromosome in a retinoic acid resistant HL-60 subline.
Leukemia research 1999;23(2):105-13.
1999: James L Slack; Robert E Gallagher
The molecular biology of acute promyelocytic leukemia.
Cancer treatment and research 1999;99():75-124.
1998: Da-Cheng Zhou; Steven Hallam; S J Lee; Robert S Klein; Peter H Wiernik; Martin S Tallman; Robert E Gallagher
Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Cancer research 1998;58(24):5770-6.
1998: Robert E Gallagher
Arsenic--new life for an old potion.
The New England journal of medicine 1998;339(19):1389-91.
1998: Wei Ding; YP Li; L M Nobile; G Grills; I Carrera; Elisabeth Paietta; Martin S Tallman; Peter H Wiernik; Robert E Gallagher
Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.
Blood 1998;92(4):1172-83.
1997: Anna C Ferrari; Nelson N Stone; J N Eyler; M Gao; John Mandeli; Pamela Unger; Robert E Gallagher; Richard Stock
Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer.
Journal of the National Cancer Institute 1997;89(20):1498-504.
1997: Robert E Gallagher; Cheryl L Willman; James L Slack; J W Andersen; YP Li; David S Viswanatha; Clara D Bloomfield; F R Appelbaum; Charles Alan Schiffer; Martin S Tallman; Peter H Wiernik
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.
Blood 1997;90(4):1656-63.
1997: YP Li; J Andersen; Arthur Zelent; S Rao; Elisabeth Paietta; Martin S Tallman; Peter H Wiernik; Robert E Gallagher
RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study.
Blood 1997;90(1):306-12.
1997: Scott Wadler; Edward L Schwartz; Hilda Haynes; R Rameau; A Quish; John Mandeli; Robert E Gallagher; S Hallam; Abbie Fields; Gary L Goldberg; F McGill; S Jennings; Robert C Wallach; Carolyn D Runowicz
All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group.
Cancer 1997;79(8):1574-80.
1995: Edward L Schwartz; S Hallam; Robert E Gallagher; Peter H Wiernik
Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia.
Biochemical pharmacology 1995;50(7):923-8.
1995: Robert E Gallagher; YP Li; S Rao; Elisabeth Paietta; J Andersen; PR Etkind; J M Bennett; Martin S Tallman; Peter H Wiernik
Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.
Blood 1995;86(4):1540-7.
1994: N Sun; X P Li; XP Hu; Elisabeth Paietta; Robert E Gallagher
Altered retinoid dose-response of retinoic acid-resistant HL-60 cells.
Blood 1994;84(12):4383-4.
1994: Elisabeth Paietta; Robert E Gallagher; P H Wiernik
Myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as FAB-M3 acute myeloid leukemia.
Blood 1994;84(8):2824-5.
1994: G E Sagayadan; Peter H Wiernik; N Sun; G Ahearn; D Thompson; Steven Hallam; XP Hu; Janice P Dutcher; Robert E Gallagher
Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease.
Leukemia research 1994;18(10):741-8.
1994: Elisabeth Paietta; J Andersen; Robert E Gallagher; J Bennett; J Yunis; Peter A Cassileth; J Rowe; Peter H Wiernik
The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
Leukemia 1994;8(7):1108-12.
1994: YP Li; F Said; Robert E Gallagher
Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-alpha.
Blood 1994;83(11):3298-302.
1994: Elisabeth Paietta; J Andersen; Janis Racevskis; Robert E Gallagher; J Bennett; J Yunis; Peter A Cassileth; Peter H Wiernik
Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.
Leukemia 1994;8(6):968-73.
1993: Robert E Gallagher
All-trans-retinoic acid in acute promyelocytic leukemia: let's get on with finding out how good it is.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):589-90.
1991: Robert E Gallagher; P H Wiernik
All-trans retinoic acid in myelogenous leukaemia.
Lancet 1991;338(8782-8783):1603.
1991: Peter H Wiernik; Janice P Dutcher; Elisabeth Paietta; W N Hittelman; R Vyas; M Strack; S Castaigne; L Degos; Robert E Gallagher
Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.
Leukemia 1991;5(6):504-9.
1991: O Saitoh; Robert E Gallagher; Michiko N Fukuda
Expression of aberrant O-glycans attached to leukosialin in differentiation-deficient HL-60 cells.
Cancer research 1991;51(11):2854-62.
1990: Edward J Lee; D E Hogge; Robert E Gallagher; Charles Alan Schiffer
Low dose 5-azacytidine is ineffective for remission induction in patients with acute myeloid leukemia.
Leukemia 1990;4(12):835-8.
1989: Robert E Gallagher; F Said; I Pua; P R Papenhausen; Elisabeth Paietta; Peter H Wiernik
Expression of retinoic acid receptor-alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid.
Leukemia 1989;3(11):789-95.
1989: S Kitagawa; H Nojiri; M Nakamura; Robert E Gallagher; Mineki Saito
Human myelogenous leukemia cell line HL-60 cells resistant to differentiation induction by retinoic acid. Decreased content of glycosphingolipids and granulocytic differentiation by neolacto series gangliosides.
The Journal of biological chemistry 1989;264(27):16149-54.
1989: E S Athan; Elisabeth Paietta; P R Papenhausen; Leonard H Augenlicht; Peter H Wiernik; Robert E Gallagher
Stability of multiple antigen receptor gene rearrangements and immunophenotype in Hodgkin's disease-derived cell line L428 and variant subline L428KSA.
Leukemia 1989;3(7):505-10.
1989: Robert E Gallagher; F de Cuevillas; C S Chang; Edward L Schwartz
Variable regulation of sensitivity to retinoic acid-induced differentiation in wild-type and retinoic acid-resistant HL-60 cells.
Cancer communications 1989;1(1):45-54.
1988: R P Wersto; F Herz; Robert E Gallagher; Leopold G Koss
Cell cycle-dependent reactivity with the monoclonal antibody Ki-67 during myeloid cell differentiation.
Experimental cell research 1988;179(1):79-88.
1988: Elisabeth Paietta; Robert E Gallagher; Peter H Wiernik; Richard J Stockert
A membrane-bound lectin responsive to monocytic maturation in the promyelocytic leukemia cell line HL-60.
Cancer research 1988;48(2):280-7.
1987: Robert E Gallagher; K J Lurie; Richard Leavitt; P H Wiernik
Effects of interferon and retinoic acid on the growth and differentiation of clonogenic leukemic cells from acute myelogenous leukemia patients treated with recombinant leukocyte-alpha A interferon.
Leukemia research 1987;11(7):609-19.
1986: Robert E Gallagher; D A Giangiulio; C S Chang; C J Glover; R L Felsted
Hyposialylation of differentiation-inducer-resistant HL-60 cells.
Blood 1986;68(6):1402-6.
1985: R L Felsted; S K Gupta; C J Glover; Robert E Gallagher
Surface membrane glycoproteins of wild-type and differentiation-inducer-resistant HL-60 cells.
Blood 1985;66(3):606-13.
1985: Robert E Gallagher; P A Bilello; Anna C Ferrari; C S Chang; Ray-Whay Chiu Yen; W A Nickols; E C Muly
Characterization of differentiation-inducer-resistant HL-60 cells.
Leukemia research 1985;9(8):967-86.
1984: Robert E Gallagher; Anna C Ferrari; A W Zulich; Ray-Whay Chiu Yen; J R Testa
Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
Cancer research 1984;44(6):2642-53.
1983: R L Felsted; S K Gupta; C J Glover; Steven Fischkoff; Robert E Gallagher
Cell surface membrane protein changes during the differentiation of cultured human promyelocytic leukemia HL-60 cells.
Cancer research 1983;43(6):2754-61.
1983: N S Young; Robert E Gallagher; S P Chen
Anti-K562 monoclonal antibodies that recognize antigens on immature hematopoietic cells.
Progress in clinical and biological research 1983;134():293-304.
1983: Robert E Gallagher; Anna C Ferrari; A W Zulich; J R Testa
Variable differentiative response of 6-thioguanine-resistant HL60 sublines: possible relationship to double-minute chromosomes.
Progress in nucleic acid research and molecular biology 1983;29():283-6.
1979: Robert E Gallagher; S Collins; J Trujillo; K McCredie; M Ahearn; S Tsai; R Metzgar; G Aulakh; R Ting; F Ruscetti; Robert C Gallo
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.
Blood 1979;54(3):713-33.
1979: P Ebbesen; C Due; J Hesse; R Kurth; G R Noble; Robert E Gallagher; A Voller; G Jensen
Elevated titer of antibodies to Simian sarcoma virus envelope antigen (gp70) and normal response to influenza virus in untreated Danish Hodgkin's patients.
International journal of cancer. Journal international du cancer 1979;24(1):1-5.
1979: S J Collins; F W Ruscetti; Robert E Gallagher; Robert C Gallo
Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide.
The Journal of experimental medicine 1979;149(4):969-74.
1979: P D Markham; F Ruscetti; S Z Salahuddin; Robert E Gallagher; Robert C Gallo
Enhanced induction of growth of B lymphoblasts from fresh human blood by primate type-C retroviruses (gibbon ape leukemia virus and simian sarcoma virus).
International journal of cancer. Journal international du cancer 1979;23(2):148-56.
1979: Marvin Reitz; F wong-Staal; W A Haseltine; D G Kleid; C D Trainor; Robert E Gallagher; Robert C Gallo
Gibbon ape leukemia virus-Hall's Island: new strain of gibbon ape leukemia virus.
Journal of virology 1979;29(1):395-400.
1978: J M Krakower; S R Tronick; Robert E Gallagher; Robert C Gallo; S A Aaronson
Antigenic characterization of a new gibbon ape leukemia virus isolate: seroepidemiologic assessment of an outbreak of gibbon leukemia.
International journal of cancer. Journal international du cancer 1978;22(6):715-20.
1978: S J Collins; F W Ruscetti; Robert E Gallagher; Robert C Gallo
Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(5):2458-62.
1978: Robert E Gallagher; A W Schrecker; C A Walter; Robert C Gallo
Oncornavirus lytic activity in the serum of gibbon apes.
Journal of the National Cancer Institute 1978;60(3):677-82.
1978: P D Markham; William Dodge; S Z Salahuddin; Robert E Gallagher
An in vitro transformation assay for SiSV-1 and HL23V using feline embryonic fibroblasts.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1978;157(2):312-8.
1978: Robert C Gallo; Robert E Gallagher; F Wong-Staal; T Aoki; P D Markham; H Schetters; F Ruscetti; M Valerio; M J Walling; R T O'Keeffe; W C Saxinger; R G Smith; D H Gillespie; Marvin Reitz
Isolation and tissue distribution of type-C virus and viral components from a gibbon ape (Hylobates lar) with lymphocytic leukemia.
Virology 1978;84(2):359-73.
1977: S J Collins; Robert C Gallo; Robert E Gallagher
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.
Nature 1977;270(5635):347-9.
1976: Marvin Reitz; N R Miller; F Wong-Staal; Robert E Gallagher; Robert C Gallo; D H Gillespie
Primate type-C virus nucleic acid sequences (woolly monkey and baboon types) in tissues from a patient with acute myelogenous leukemia and in viruses isolated from cultured cells of the same patient.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(6):2113-7.
1976: E Chan; W P Peters; R W Sweet; T Ohno; D W Kufe; S Spiegelman; Robert C Gallo; Robert E Gallagher
Characterisation of a virus (HL23V) isolated from cultured acute myelogenous leukaemic cells.
Nature 1976;260(5548):266-8.
1976: H Okabe; R V Gilden; M Hatanaka; J R Stephenson; Robert E Gallagher; S A Aaronson; Robert C Gallo; S R Tronick
Immunological and biochemical characterisation of type C viruses isolated from cultured human AML cells.
Nature 1976;260(5548):264-6.
1975: Robert E Gallagher; S Z Salahuddin; W T Hall; K B McCredie; Robert C Gallo
Growth and differentiation in culture of leukemic leukocytes from a patient with acute myelogenous leukemia and re-identification of type-C virus.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(10):4137-41.
1975: N M Teich; R A Weiss; S Z Salahuddin; Robert E Gallagher; D H Gillespie; Robert C Gallo
Infective transmission and characterisation of a C-type virus released by cultured human myeloid leukaemia cells.
Nature 1975;256(5518):551-5.
1975: H Mondal; Robert E Gallagher; Robert C Gallo
RNA-directed DNA polymerase from human leukemic blood cells and from primate type-C virus-producing cells: high- and low-molecular-weight forms with variant biochemical and immunological properties.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(3):1194-8.
1975: Robert E Gallagher; Robert C Gallo
Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells.
Science (New York, N.Y.) 1975;187(4174):350-3.
1975: Robert C Gallo; W C Saxinger; Robert E Gallagher; N Miller; D Gillespie
Evolutionary nature of human reverse transcriptase and of viral-related DNA synthesized in vitro by human leukemic cells.
Bibliotheca haematologica 1975;(40):569-76.
1975: Robert C Gallo; Robert E Gallagher; N R Miller; H Mondal; W C Saxinger; R J Mayer; R G Smith; D H Gillespie
Relationships between components in primate RNA tumor viruses and in the cytoplasm of human leukemic cells: implications to leukemogenesis.
Cold Spring Harbor symposia on quantitative biology 1975;39 Pt 2():933-61.
1974: Robert C Gallo; Robert E Gallagher; M G Sarngadharan; P Sarin; Marvin Reitz; N Miller; D H Gillespie
The evidence for involvement of type C RNA tumor viruses in human acute leukemia.
Cancer 1974;34(4 Suppl):suppl:1398-405.
1974: Robert E Gallagher; R G Smith; D H Gillespie; Robert C Gallo
Primate type-C virus-related reverse transcriptase and RNA in human acute leukemia cells as potential diagnostic markers.
Annals of clinical and laboratory science 1974;4(5):372-82.
1974: N R Miller; W C Saxinger; Marvin Reitz; Robert E Gallagher; A M Wu; Robert C Gallo; D Gillespie
Systematics of RNA tumor viruses and virus-like particles of human origin.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(8):3177-81.
1974: Robert C Gallo; Robert E Gallagher; R C Ting; R G Smith; D H Gillespie; A M Wu
Interference with formation and expression of RNA tumor virus information: rationale and experimental results.
Cancer chemotherapy reports. Part 1 1974;58(4):579-93.
1974: Robert E Gallagher; G J Todaro; R G Smith; D M Livingston; Robert C Gallo
Relationship between RNA-directed DNA polymerase (reverse transcriptase) from human acute leukemic blood cells and primate type-C viruses.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(4):1309-13.
1974: Robert E Gallagher; H Mondal; D P Miller; G J Todaro; D H Gillespie; Robert C Gallo
Relatedness of RNA and reverse transcriptase from human acute myelogenous leukemia cells and from RNA tumor viruses.
Hämatologie und Bluttransfusion 1974;14():185-96.
1974: Robert C Gallo; Robert E Gallagher
Are viruses concerned in the etiology of human leukemia?
Series haematologica 1974;7(2):224-73.
1973: S E Wright; Robert E Gallagher; R C Ting; Robert C Gallo
Transfer RNA methylases and transfer RNA-methylated bases of polyoma virus-transformed and spontaneously transformed mouse culture cells.
Cancer research 1973;33(10):2513-7.
1973: Robert E Gallagher; Robert C Gallo
Chromatographic analyses of isoaccepting tRNAs from avian myeloblastosis virus.
Journal of virology 1973;12(3):449-57.
1973: Robert E Gallagher; A S Levine; D H Gillespie; Robert C Gallo
Lack of sequence homology between the 70S RNA of various RNA tumor viruses and the DNA of simian virus 40 or polyoma virus.
Journal of virology 1973;11(6):1027-9.
1972: Robert E Gallagher; C A Walter; Robert C Gallo
Uptake and aminoacylation of exogenous transfer RNA by mouse leukemia cells.
Biochemical and biophysical research communications 1972;49(3):782-92.
1972: Robert E Gallagher; R C Ting; Robert C Gallo
A common change of aspartyl-tRNA in polyoma- and SV40 -transformed cells.
Biochimica et biophysica acta 1972;272(4):568-82.
1971: Robert E Gallagher; R C Ting; Robert C Gallo
Transfer RNA methylase alterations in polyoma transformed rat embryo culture cells.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1971;136(3):819-23.